AIM - AIM ImmunoTech Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
185
140
367
437
92
Cost of Revenue
866
893
884
1,183
1,108
Gross Profit
-681
-753
-517
-746
-1,016
Operating Expense
12,161
11,690
10,979
10,670
12,788
Operating Income
-12,842
-12,443
-11,496
-11,416
-13,804
Net Non Operating Interest Income Expense
-405
-338
-456
-51
129
Other Income Expense
3,271
3,248
2,139
3,208
6,173
Pretax Income
-9,976
-9,533
-9,813
-8,259
-7,502
Net Income Common Stockholders
-9,976
-9,533
-9,813
-8,259
-7,502
Diluted NI Available to Com Stockholders
-9,976
-9,533
-9,813
-8,259
-7,502
Basic EPS
-
-0.0026
-0.0097
-0.0128
-0.015
Diluted EPS
-
-0.0026
-0.0097
-0.0128
-0.015
Basic Average Shares
-
3,643
1,004
651.721
495.862
Diluted Average Shares
-
3,643
1,004
651.721
495.862
Total Operating Income as Reported
-12,842
-12,443
-11,496
-11,416
-13,804
Total Expenses
13,027
12,583
11,863
11,853
13,896
Net Income from Continuing & Discontinued Operation
-9,976
-9,533
-9,813
-8,259
-7,502
Normalized Income
-12,471
-11,915
-11,675
-8,259
-13,675
Interest Income
98
89
46
88
129
Interest Expense
503
427
502
139
0
Net Interest Income
-405
-338
-456
-51
129
EBIT
-9,473
-9,106
-9,311
-8,120
-7,502
EBITDA
-8,511
-
-
-
-
Reconciled Cost of Revenue
866
893
884
1,183
1,108
Reconciled Depreciation
962
792
878
1,011
1,303
Net Income from Continuing Operation Net Minority Interest
-9,976
-9,533
-9,813
-8,259
-7,502
Total Unusual Items Excluding Goodwill
2,495
2,382
1,862
0
6,173
Total Unusual Items
2,107
2,382
1,862
0
6,173
Normalized EBITDA
-11,006
-10,696
-10,295
-7,109
-12,372
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0